Results 141 to 150 of about 1,151 (165)
Some of the next articles are maybe not open access.

Therapeutic applications of betulinic acid nanoformulations

Annals of the New York Academy of Sciences, 2018
AbstractBetulinic acid (BA), a naturally occurring plant‐derived pentacyclic triterpenoid, has gained attention in recent years owing to its broad‐spectrum biological and medicinal properties. Despite the pharmacological activity of BA, it has been associated with some drawbacks, such as poor aqueous solubility and short half‐life in vivo, which limit ...
Ankit, Saneja   +5 more
openaire   +2 more sources

Nanoformulations for Cancer Therapy

2017
Recent progress in the field of science and technology has catered us with new dimensions to understand the origin and complexity of biological events associated with the development of cancer. Growth of cancer is a multi-stage process which involves diverse genetic alterations and cellular signalling pathways, responsible for the development and ...
Amaresh Kumar Sahoo   +2 more
openaire   +1 more source

Nanoformulations: Opportunities and Challenges

2020
Nanotechnology has revolutionized each aspect of healthcare along with other associated sciences. Drug-loaded nanocarriers and nanocrystalline active ingredients have overcome various challenges faced by conventional therapy like limited bioavailability, multiple drug resistance, poor patient compliance, adverse drug reactions, particularly untoward ...
Lubna Siddiqui   +3 more
openaire   +1 more source

Nanoformulation-based sequential combination cancer therapy

Advanced Drug Delivery Reviews, 2017
Although combining two or more treatments is regarded as an indispensable approach for effectively treating cancer, the traditional cocktail-based combination therapies are seriously limited by coordination issues that fail to account for differences in the pharmacokinetics and action sites of each drug.
Gayong, Shim   +4 more
openaire   +2 more sources

Current development in nanoformulations of docetaxel

Expert Opinion on Drug Delivery, 2012
Docetaxel (DTX) has been proven as one of the most important cytotoxic agents, and its clinical efficacy against many cancers is superior to paclitaxel. DTX in commercial formulation contains the non-ionic surfactant Tween 80 (polysorbate 80) and 13% ethanol; the side effects caused by DTX and the solvent have considerably limited its clinical use.
Qi, Tan   +5 more
openaire   +2 more sources

Nanoformulations for Wound Infections

2017
Nanotechnology is promising science, which plays an important role in revolutionizing the medical and pharmaceutical fields in near future. The widespread applications of nanotechnology have already offered advantages to biomedical problem including wound healing.
Avinash P. Ingle   +7 more
openaire   +1 more source

Lipid-based nanoformulations for peptide delivery

International Journal of Pharmaceutics, 2016
Nanoformulations have attracted a lot of attention because of their size-dependent properties. Among the array of nanoformulations, lipid nanoformulations (LNFs) have evoked increasing interest because of the advantages of their high degree of biocompatibility and versatility.
Matougui, Nada   +6 more
openaire   +3 more sources

Nanoformulations for Vaginal Therapy

2017
Nanomedicine offers the means to improve the therapy of various disorders, including genital infections, hormone replacement therapy, and vaginal dryness. Although genital infections affect both genders, we focused on the application of nanoformulations in the treatment of vaginal infections and the disorders affecting women.
Škalko-Basnet, Nataša, Vanić, Željka
openaire   +1 more source

Nanoformulations for Postharvest Applications

The application of nanomaterials in postharvest preservation has been widely investigated and tested as a sustainable alternative or complementary method to conventional technologies. Nanoformulations based on natural bioactive extracts, essential oils, and metallic nanoparticles as films, coatings, and hydrogels, and delivery nanosystems as ...
Raul Remor Dalsasso   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy